Eugenol: Propiedades farmacológicas y toxicológicas. Ventajas y desventajas de su uso

Revista Cubana de Estomatologia

Volumn 39, Issue 2, 2002, Pages 139-156

  Escobar, Raimara González ^a,b  

^a CENTRO DE INVESTIGACIÓN Y DESARROLLO DE MEDICAMENTOS CIDEM   (Cuba)

^b Centro de Información Farmacéutica   (Cuba)

Author keywords

Dental materials therapeutic use; Eugenol pharmacology; Eugenol toxicity; Risk assessment

Indexed keywords

EID: 52649104025     PISSN: 00347507     EISSN: 00347507     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Garza Padilla E, Toranzo Fernández JM. Revista ADM, Asociación Dental Mexicana. 87 Congreso Mundial FDIXXV Congreso Nacional e Internacional. ADM; 1998;55:46-50.
2. 87 Congreso Mundial FDIXXV Congreso Nacional e Internacional. Volumen LV;46-50.
3. Remington's Pharmaceutical Sciences. 18th ed. Pennsylvania: Mack Publishing Co;1990:1056,1328.
4. The Complete Drug Reference. 32nd ed. Edit. Martindale; 1999:1564-5,1578.
5. Briseño B, Willers Lausen B. Root canal sealer cytotoxity on human gingival fibroblasts. JJ Endodon 1990;16:383.
6. Markowitz K, Moynihan Mil Liu, Kim Syngcuk K. Biologic properties of Eugenol and Zinc oxide-eugenol. Oral Surg Oral Med Oral Pathol 1992;73:729-39.
7. Gossel TA. Relieving the pain of toothache. US-Pham 1986;11:23-4,28,31-2.
8. Pabla T, Gulati MS, Mohan U. Evaluation of antimicrobial efficacy of various root canal filling materials for primary teeth. J Indian Soc Pedod Prev Dent 1997;15:134-8.
9. Toda S, Ohnishi M, Kimura M, Toda T. Inhibitory effects of eugenol and related compounds on lipid peroxidation induced by reactive oxygen. Planta- Med 1994;60:282.
10. Sukumaran K, Unnikrishnan MC, Kuttan R. Inhibition of tumor promotion in mice bay eugenol. Indian Physiol Pharmacol 1994;38:306-8.
11. Reddy ACP, Lokesh BR. Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron. Mol Cell Biochem 1994;137:1-8.
12. Nagababu E, Lakshmaiah N. Inhibition of microsomal lipid peroxidation and monooxigenase activities by eugenol. Free Radic Res 1994; 20:253-66.
13. Garg SC, Siddiqui N. Antifungal activity of essential oil isolates. Pharmazie 1992;47:467-8.
14. Didry N, Dubreuil L, Pinkas M. Activity of thymol, carvacrol, cinnamaldehyde and eugenol on oral bacteria. Pharm Acta Helv 1994;69:25-8.
15. Going RG, Mitchen JE. Cements for permanent luting: a summarizing review. J Am Dent Assoc 1975;91:107-17.
16. Hume W. The pharmacology and toxicology and properties of Zinc-Eugenol. JADA 1986;113:789.
17. Rajakamur UV, Rao MNA. Dehydrozingerone and isoeugenol as inhibitor of lipid peroxidation and as free radical scavengers. Biochem Pharmacol 1993;46:2067-72.
18. Di Giuseppe EV. Aplicación clínica del Agregado Trióxido Mineral (MTA) en endodoncia. Boletín Científico BIOMATERIALES de la Sociedad Colombiana de Operatoria Dental y Biomateriales 1996; IV (3).
19. Arens D, Torabinejad M. Repair of furcal perforations with mineral trioxide aggregate: Two case reports. Oral Surg 1996;82:84-8.
20. Baldíssara P, Comin G, Martone F, Scotti-R. Comparative study of the marginal microleakage of six cements in fixed provisional crowns. Prosthet Dent 1998;80:417-22.
21. Culbreath TE, Davis GM, West NM, Jackson A. Treating internal resorption using a syringeable composite resin. J Am Dent Assoc 2000;31:493.
22. Murray PE, About I, Lumley PJ, Smith G, Franquin JC. Postoperative pulpal and repair responses. J Am Dent Assoc 2000;131:321-9.
23. Lee SY, et al. Retentive and. Retentive and compressive strengths of modified zinc oxide-eugenol cements. J Dent 2000;28:69-75.
24. Rosentiel SF, et al. Dental luting agents: A review of the current literature. J Prosthet Dent 1998;80:280-301.
25. Tanomaru-Filho M, Leonardo MR, Silva LA, Utrilla LS. Effect of different root canal sealers on periapical repair of teeth with chronic periradicular periodontitis. Int Endod J 1998;31:85-9.
26. Demirci M, Ucok Kucukkeles N, Soydan N. Pulp reaction to a tricure resin-modified glass ionomer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:712-9.
27. Culbreath TE, Davis GM, West NM, Jackson A. Treating internal reabsorption using a syringeable composite resin. J Am Dent Assoc 2000;131:493-5.